Titlebook: Isolated Liver Perfusion for Hepatic Tumors; Karl J. Oldhafer,Hauke Lang,Rudolf Pichlmayr Conference proceedings 1998 Springer-Verlag Berl

Detoxification

Indication for Isolated Hyperthermic Liver Perfusion: A Surgeon’s View appears to provide distinct benefits in a number of situations but the scientific evidence is still incomplete. In our view the present indications for use of isolated hyperthermic perfusion of the liver are:

syring

抱負

Feckless

Boycott

Monitoring Leakage During Isolated Hepatic Perfusions an organ that, apart from the vessels and the bile duct, can be separated completely from the surrounding body tissue. Leakage can still occur, however, with possible sites at the veins connecting to the caval vein. The caval vein should be freed as much as possible. Drug levels in the perfusate a

Inertia

accessory

Percutaneous Isolated Liver Chemoperfusion for Treatment of Unresectable Malignant Liver Tumors: Tecfusion (HVI-CHP) for the treatment of malignant liver tumors. We report here the surgical technique, pharmacokinetics, and effectiveness of PILP in multiple advanced liver tumors. Twenty-eight patients with hepatocellular carcinoma (HCC) and 18 with metastatic liver tumors underwent a total of 61 PI

昏睡中

Phase I/II Studies of Isolated Hepatic Perfusion with Mitomycin C or Melphalan in Patients with Colotal (rats and pigs) and clinical isolated hepatic perfusion (IHP) technique to exploit maximally the steep dose-response relation of many anticancer drugs. In this overview we present our experimental and clinical results with mitomycin C (MMC) and melphalan (.-PAM). In rats, treatment with a four t

大包裹

Molecular Mechanisms of TNF Receptor-Mediated Signalingal years substantial progress has been made toward a better understanding of how a single cytokine is able to exert obviously opposing effects (e. g., apoptosis and growth). This review focuses on the recently discovered TNF-receptor (TNFR)-associated proteins involved in the activation of intracell

松軟無力

Isolated Hepatic Perfusion with Tumor Necrosis Factor , and Melphalan: Experimental Studies in Pigs ase I study in humans. IHP was performed with inflow catheters in the hepatic artery and portal vein and an outflow catheter in the caval vein. An extracorporeal venovenous bypass was used. IHP consisted of a 60-min perfusion with hyperthermia (> 41 °C). For the pig protocol rhTNF. 50 μg/kg alone (.